BOCA RATON, Fla., May 3 /PRNewswire-FirstCall/ -- Nabi Biopharmaceuticals announced today that Thomas H. McLain, chairman, chief executive officer and president, will be presenting at the Bank of America Health Care Conference 2006 on May 16, 2006 at 11:20 am PT/2:20 pm ET at The Four Seasons Hotel, 3960 Las Vegas Blvd., South, Las Vegas, Nevada. Mr. McLain will present a company overview.
The presentation will be webcast live at: http://www.veracast.com/webcasts/bas/healthcare06/id15106602.cfm The webcast presentation will be available through June 16, 2006. About Nabi Biopharmaceuticals
Nabi Biopharmaceuticals leverages its experience and knowledge in powering the immune system to develop and market products that fight serious medical conditions. The company has three products on the market today: PhosLo(R) (calcium acetate), Nabi-HB(R) [Hepatitis B Immune Globulin (Human)], and Aloprim(TM) (allopurinol sodium) for Injection. Nabi Biopharmaceuticals is focused on developing products that address unmet medical needs and offer commercial opportunities in our core business areas: Gram-positive bacterial infections, hepatitis and transplant, kidney disease (nephrology) and nicotine addiction. For a complete list of pipeline products, please go to: http://www.nabi.com/pipeline/index.php . The company is headquartered in Boca Raton, Florida. For additional information about Nabi Biopharmaceuticals, please visit our website: http://www.nabi.com .
Audio: http://www.veracast.com/webcasts/bas/healthcare06/id15106602.cfmNabi Biopharmaceuticals
CONTACT: Tom Rathjen, Vice President, Investor Relations, NabiBiopharmaceuticals, +1-561-989-5800
Web site: http://www.nabi.com/
